HRP20120660T1 - Tekuće formulacije lh - Google Patents
Tekuće formulacije lh Download PDFInfo
- Publication number
- HRP20120660T1 HRP20120660T1 HRP20120660AT HRP20120660T HRP20120660T1 HR P20120660 T1 HRP20120660 T1 HR P20120660T1 HR P20120660A T HRP20120660A T HR P20120660AT HR P20120660 T HRP20120660 T HR P20120660T HR P20120660 T1 HRP20120660 T1 HR P20120660T1
- Authority
- HR
- Croatia
- Prior art keywords
- formulation according
- luteinizing hormone
- concentration
- formulation
- hlh
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07119832 | 2007-11-01 | ||
| US448107P | 2007-11-28 | 2007-11-28 | |
| PCT/EP2008/064679 WO2009056569A1 (en) | 2007-11-01 | 2008-10-29 | Lh liquid formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20120660T1 true HRP20120660T1 (hr) | 2012-09-30 |
Family
ID=39167502
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20120660AT HRP20120660T1 (hr) | 2007-11-01 | 2008-10-29 | Tekuće formulacije lh |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US8664369B2 (https=) |
| EP (1) | EP2219607B1 (https=) |
| JP (1) | JP5551601B2 (https=) |
| KR (1) | KR101513181B1 (https=) |
| CN (1) | CN101842083B (https=) |
| AU (1) | AU2008320844B2 (https=) |
| BR (1) | BRPI0818324B8 (https=) |
| CA (1) | CA2700662C (https=) |
| CY (1) | CY1113121T1 (https=) |
| DK (1) | DK2219607T3 (https=) |
| EA (1) | EA019432B1 (https=) |
| EC (1) | ECSP10010224A (https=) |
| ES (1) | ES2393233T3 (https=) |
| HR (1) | HRP20120660T1 (https=) |
| IL (1) | IL205105A (https=) |
| MX (1) | MX2010004639A (https=) |
| MY (1) | MY153976A (https=) |
| NZ (1) | NZ583991A (https=) |
| PL (1) | PL2219607T3 (https=) |
| PT (1) | PT2219607E (https=) |
| RS (1) | RS52566B (https=) |
| SI (1) | SI2219607T1 (https=) |
| UA (1) | UA101484C2 (https=) |
| WO (1) | WO2009056569A1 (https=) |
| ZA (1) | ZA201001907B (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102007143B (zh) | 2008-01-09 | 2015-08-26 | 塞诺菲-安万特德国有限公司 | 具有超延迟时效特征的新型胰岛素衍生物 |
| CN102256618A (zh) | 2008-10-17 | 2011-11-23 | 赛诺菲-安万特德国有限公司 | 胰岛素和glp-1激动剂的组合 |
| JP2011001273A (ja) * | 2009-06-16 | 2011-01-06 | Eci Inc | ｅＭＩＰを有効成分とする水溶性製剤 |
| PL2451437T3 (pl) * | 2009-07-06 | 2017-05-31 | Sanofi-Aventis Deutschland Gmbh | Wodne preparaty insuliny zawierające metioninę |
| NZ599847A (en) | 2009-11-13 | 2013-09-27 | Sanofi Aventis Deutschland | Pharmaceutical composition comprising a glp-1 agonist and methionine |
| TR201809460T4 (tr) | 2009-11-13 | 2018-07-23 | Sanofi Aventis Deutschland | Bir GLP- 1-agonisti, bir insülin ve metiyonin içeren farmasötik bileşim. |
| RU2553375C2 (ru) * | 2010-02-12 | 2015-06-10 | Интас Биофармасьютикалс Лимитед | Жидкий состав фолликулостимулирующего гормона |
| WO2012028172A1 (en) | 2010-08-30 | 2012-03-08 | Sanofi-Aventis Deutschland Gmbh | Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2 |
| US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
| CN102293756A (zh) * | 2011-08-24 | 2011-12-28 | 蚌埠丰原涂山制药有限公司 | 一种尿促性素冻干粉针剂及其制备方法 |
| AR087693A1 (es) | 2011-08-29 | 2014-04-09 | Sanofi Aventis Deutschland | Combinacion farmaceutica para uso en el control glucemico en pacientes con diabetes de tipo 2 |
| TWI559929B (en) | 2011-09-01 | 2016-12-01 | Sanofi Aventis Deutschland | Pharmaceutical composition for use in the treatment of a neurodegenerative disease |
| JP2016505601A (ja) * | 2012-12-26 | 2016-02-25 | ウォックハート リミテッド | 医薬組成物 |
| TWI780236B (zh) | 2013-02-04 | 2022-10-11 | 法商賽諾菲公司 | 胰島素類似物及/或胰島素衍生物之穩定化醫藥調配物 |
| EP2968391A1 (en) | 2013-03-13 | 2016-01-20 | Moderna Therapeutics, Inc. | Long-lived polynucleotide molecules |
| CN105960249B (zh) | 2014-01-09 | 2021-03-16 | 赛诺菲 | 胰岛素类似物和/或胰岛素衍生物的稳定化药物制剂 |
| JP6723921B2 (ja) | 2014-01-09 | 2020-07-15 | サノフイＳａｎｏｆｉ | インスリンアナログおよび／またはインスリン誘導体の、グリセリンを含まない安定化された医薬製剤 |
| US9895423B2 (en) | 2014-01-09 | 2018-02-20 | Sanofi | Stabilized pharmaceutical formulations of insulin aspart |
| PE20171622A1 (es) | 2014-12-12 | 2017-11-02 | Sanofi Aventis Deutschland | Formulacion de relacion fija de insulina glargina/lixisenatida |
| TWI748945B (zh) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | 第２型糖尿病病患治療 |
| TW201705975A (zh) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | 第２型糖尿病病患之治療 |
| GB201603280D0 (en) * | 2016-02-24 | 2016-04-13 | Ferring Bv | Stable liquid gonadotropin formulation |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE64738B1 (en) * | 1990-03-20 | 1995-09-06 | Akzo Nv | Stabilized gonadotropin containing preparations |
| IT1250075B (it) * | 1991-12-18 | 1995-03-30 | Serono Cesare Ist Ricerca | Composizioni farmaceutiche contenenti gonadotropine. |
| US5681302A (en) * | 1994-06-14 | 1997-10-28 | Minnesota Mining And Manufacturing Company | Elastic sheet-like composite |
| WO1996029095A1 (en) * | 1995-03-21 | 1996-09-26 | Applied Research Systems Ars Holding N.V. | Hcg liquid formulations |
| IL122732A0 (en) * | 1997-01-15 | 1998-08-16 | Akzo Nobel Nv | Liquid gonadotropin-containing formulation its preparation and a device containing same |
| CN1309567A (zh) * | 1998-07-23 | 2001-08-22 | 伊莱利利公司 | Fsh和fsh变体制剂,产品和方法 |
| DE602004019761D1 (de) * | 2003-01-08 | 2009-04-16 | Novartis Vaccines & Diagnostic | Stabilisierte wässrige zusammensetzungen mit gewebefaktorinhibitor (tfpi) oder gewebefaktorinhibitor-variante |
| US7387998B2 (en) | 2003-03-28 | 2008-06-17 | New York University | STQ peptides |
| CA2518903C (en) * | 2003-04-02 | 2013-02-05 | Ares Trading S.A. | Liquid pharmaceutical formulations of fsh and lh together with a non-ionic surfactant |
-
2008
- 2008-10-29 US US12/681,688 patent/US8664369B2/en active Active
- 2008-10-29 EA EA201070549A patent/EA019432B1/ru not_active IP Right Cessation
- 2008-10-29 RS RS20120484A patent/RS52566B/sr unknown
- 2008-10-29 EP EP08844750A patent/EP2219607B1/en active Active
- 2008-10-29 CA CA2700662A patent/CA2700662C/en not_active Expired - Fee Related
- 2008-10-29 PT PT08844750T patent/PT2219607E/pt unknown
- 2008-10-29 DK DK08844750.3T patent/DK2219607T3/da active
- 2008-10-29 HR HRP20120660AT patent/HRP20120660T1/hr unknown
- 2008-10-29 UA UAA201006712A patent/UA101484C2/ru unknown
- 2008-10-29 BR BRPI0818324A patent/BRPI0818324B8/pt active IP Right Grant
- 2008-10-29 MY MYPI2010001950A patent/MY153976A/en unknown
- 2008-10-29 NZ NZ583991A patent/NZ583991A/en unknown
- 2008-10-29 MX MX2010004639A patent/MX2010004639A/es active IP Right Grant
- 2008-10-29 WO PCT/EP2008/064679 patent/WO2009056569A1/en not_active Ceased
- 2008-10-29 AU AU2008320844A patent/AU2008320844B2/en active Active
- 2008-10-29 CN CN2008801145250A patent/CN101842083B/zh active Active
- 2008-10-29 KR KR1020107012131A patent/KR101513181B1/ko active Active
- 2008-10-29 ES ES08844750T patent/ES2393233T3/es active Active
- 2008-10-29 PL PL08844750T patent/PL2219607T3/pl unknown
- 2008-10-29 SI SI200830735T patent/SI2219607T1/sl unknown
- 2008-10-29 JP JP2010531519A patent/JP5551601B2/ja active Active
-
2010
- 2010-03-17 ZA ZA2010/01907A patent/ZA201001907B/en unknown
- 2010-04-15 IL IL205105A patent/IL205105A/en active IP Right Grant
- 2010-05-31 EC EC2010010224A patent/ECSP10010224A/es unknown
-
2012
- 2012-09-13 CY CY20121100836T patent/CY1113121T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20120660T1 (hr) | Tekuće formulacije lh | |
| JP2011502968A5 (https=) | ||
| AR082024A1 (es) | Formulacion de anticuerpo contra ox40l humano | |
| HRP20110801T1 (hr) | Tekući oblik fsh | |
| HRP20110444T1 (hr) | Formulacije paratiroidnih hormona i njihove uporabe | |
| HRP20200998T1 (hr) | Postupak i sastav za liječenje okularne hipertenzije i glaukoma | |
| JP2911496B2 (ja) | 生理活性ポリペプチド含有高吸収性経膣剤 | |
| NZ629261A (en) | Pharmaceutical formulations of tnf-alpha antibodies | |
| HRP20191843T1 (hr) | Mikobakterijski antigenski pripravak | |
| HRP20250382T1 (hr) | Farmaceutski pripravak koji sadrži karbetocin | |
| TW201630622A (zh) | 速效胰島素組合物 | |
| HRP20200434T1 (hr) | Stabilne vodene formulacije adalimumaba | |
| JP2015527402A5 (https=) | ||
| JP2012519695A5 (https=) | ||
| HRP20240635T1 (hr) | Dugodjelujući hormoni rasta i postupci proizvodnje istog | |
| CO6150127A2 (es) | Formulaciones de flibanserina y metodo para fabricarlas | |
| TWI635874B (zh) | 艾妥鈣塞(etelcalcetide)(amg 416)之穩定液體調配物 | |
| JP2016539921A5 (https=) | ||
| HRP20230929T1 (hr) | Stabilni pripravci semaglutida i njihova upotreba | |
| RU2015115127A (ru) | Жидкие лекарственные композиции апиксабана | |
| JP2015531377A5 (https=) | ||
| CN102821782B (zh) | 促卵泡激素的液体配制品 | |
| WO2016038521A1 (en) | Pharmaceutical compositions of liraglutide | |
| HRP20200196T1 (hr) | Fiziološki balansirane injektabilne formulacije fosnetupitanta | |
| HRP20140676T1 (hr) | Formulacije deoksikolne kiseline i njezinih soli |